A fundamental question remains unanswered which I seek to address in this research: What is the actual value of novelty in pharmaceuticals to consumers?…Read More
Valuing Novelty in Consumer Demand for Pharmaceuticals
Charu Gupta
FDA Regulation and Innovation in the Pharmaceutical Industry
Standard economic theory recognizes a trade-off inherent in intellectual property protection between increased incentives for firms to innovate due to potential monopoly rights and the deadweight loss from those rights.…Read More
Firm Scope and Spillovers From New Product Innovation: Evidence From Medical Devices
When firms span related product categories, spillovers across categories become central to firm strategy and industrial policy, due to their potential to foreclose competition and affect innovation incentives. …Read More
The Impact of Funding Sources on the Rate and Direction of Academic Biomedical Innovation
Given the large and growing role of academic entrepreneurs and inventors via patents, start-up development, and university-industry relationships, understanding how funding sources may impact academic scientists’ incentives is a crucial area for innovation research, particularly in the biomedical sciences. …Read More
From Invention to Innovation: A Multi-Study Investigation of Firm Strategy and Outcomes in Clinical Trials
The translation of invention to innovation is a topic that has received significant research attention in recent times. Scholars have recognized that our understanding of the factors that shape whether and when innovative technologies arise and transform industries cannot be complete without comprehending how scientific or technological discovery evolves into commercial adoption. …Read More